"Key Drivers Impacting Executive Summary Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Size and Share The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period Analysis and discussion of important...

Introduction The Global Achalasia Cardia Market is witnessing a steady rise as awareness about esophageal motility disorders and advancements in minimally invasive treatments continue to expand. Achalasia cardia is a rare but chronic disorder of the esophagus, characterized by difficulty in swallowing due to impaired relaxation of the lower esophageal sphincter. Although relatively...

Minimally Invasive Surgical Instruments Market Overview, Trends, and Future Growth Outlook (2025–2033) The Minimally Invasive Surgical (MIS) Instruments Market is revolutionizing the global healthcare industry with advanced technology and improved patient outcomes. Market Value (2025): USD 29.6 billion Projected Value (2033): USD 52.2 billion...